It was reported that, nasal nitric oxide (nNO) is continuously released in the paranasal sinuses which acts as antibacterial and antiviral agent and improves mucociliary clearance in sinuses environment. The levels of nasal nitric oxide (nNO) are significantly changed with inflammatory stimuli as well as with medical or surgical treatment for chronic sinusitis. The present systematic review is aimed at evaluating the role of nNO as biomarker for monitoring chronic sinusitis. A webbased search was conducted in MEDLINE with inclusion criteria of human studies in English language that aimed to evaluate the role of nNO as in monitoring chronic sinusitis. Study designs adoptedwereobservational studies or clinical trials with comparisons between patient with chronic sinusitis in study group and control group of patients with flu or healthy population. The outcome assessed was the level of nNO in both groups. Data were collected for characteristics of included study such as study design, sample size, mean age, type and location of sinusitis, and technique and procedures used to monitor nitric oxide. The search on the monitoring of chronic sinusitis using nasal Nitric oxide (nNO) as marker of sinus health resulted in 97 articles, of them 81 articles were irrelevant and six articles were reviews. The included studies in this review were 10 studies. Overall findings showed that significantly lower levels of Nasal NO were reported in the patients with chronic rhinosinusitis (CRS) (irrespective of nasal polyps or allergic rhinitis concomitance) compared to healthy volunteers. The lower levels of Nasal NO in chronic rhinosinusitis are related to the decreasing of NO metabolites. The nasal nitric oxide could be employed as a good biomarker for monitoring the sinus health. The lower levels of nasal NO are indicators to the incidence ofchronic sinus inflammation in patients with chronic rhinosinusitis (CRS) These lower levels of nasal nitric oxide increase significantly after sinus therapy or surgical treatment.
INTRODUCTION
Chronic rhinosinusitis (CRS) is clinically described as chronic inflammation of the paranasal sinuses. Many individuals, especially in developed countries,have chronic rhinosinusitis 1 . Chronic rhinosinusitis may be infectious, allergic, seasonal or perennial and may be with or without nasal polyps 2 . Chronic rhinosinusitis can be associated with many health problems such as morbidity of patients and high health care costs 3 . Therefore, accurate diagnostic and rapid treatment for chronic rhinosinusitis must be done. Nitric oxide (NO) is an important signaling molecule produced by NO synthases (NOS) in the respiratory tract with maximum measured levels in the paranasal sinuses 4 . It was reported that, nasal nitric oxide (nNO) is continuously released in the paranasal sinuses which acts as antibacterial and antiviral agent and improve mucociliary clearance in sinuses environment 5 . The levels of nasal nitric oxide (nNO) are significantly changed with inflammatory stimuli 6 as well as with medical or surgical treatment for chronic sinusitis 7, 8 . It was reported that, inflammatory stimuli induced NO synthesis (NOS) to produce large amounts of NO in the airway inflammatory diseases 6 . Conversely, Colantonioet al. 9 indicated that low concentrations of nNO have been measured in patients with chronic rhinosinusitis with nasal polyposis (CRSNP). Nasal NO levels significantly increased in patients with CRSNP after medical or surgical treatment 7, 8 and this change in the level of nitric oxide could be measured easily in the nasal cavity and employed as sensitive and noninvasive markers for diagnosis of chronic sinusitis. The present systematic review is aimed at evaluating the role of nNO as biomarker for monitoring chronic sinusitis Figure 1 .
Figure 1 Flow diagram of the included studies in the systematic review
A web-based search was conducted in MEDLINE using search terms (Nitric Oxide) AND (Sinusitis OR Rhinosinusitis OR Sinus) AND (Assessment OR Evaluation OR Monitoring). The inclusion criteria which were applied represented by human studies in English language published before 1 st of March 2018 which aimed to evaluate the role of nNO as in monitoring chronic sinusitis. Study designs were prospective observational studies or clinical trials with comparisons between patient with chronic sinusitis in study group and control group of patients with flu or healthy population. The outcome assessed was the level of nNO in both groups. Data were collected for characteristics of included study such as study design, sample size, mean age, type and location of sinusitis, and technique and procedures used to monitor nitric oxide. The extracted data were discussed in a qualitative synthesis of data and presented in Table 1 . 
nNO= nasal nitric acid, CRSwNP= Chronic rhinosinusitis with nasal polyps, CRSsNP= Chronic rhinosinusitis without nasal polyps
The search on the monitoring of chronic sinusitis using nasal Nitric oxide (nNO) as marker of sinus health resulted in 97 articles, of them 81 articles were irrelevant and six articles were reviews. The included studies in this review were 10 studies [14] [15] [16] [17] [18] [19] [20] [22] [23] [24] . Overall sample size ranged between 12 to 187 patients. In general, all included studies in this review showed lower levels of Nasal NO measured in patients with chronic rhinosinusitis (CRS) either with nasal polyps (CRSwNP) or without nasal polyps (CRSsNP) or chronic rhinosinusitis (CRS) with polyps and allergic rhinitis when compared to control subjects. The report carried out by Frendøet al. 10 revealed that, nNO levels were significantly decreased in chronic rhinosinusitis patients with nasal polyps (CRSwNP) compared to that measured in controls. The same results were recorded by Torrettaet al. 15 and Jeonget al. 17 . In addition to that the study of Jeong, et al. 17 recorded significantly lower amounts of nNO in chronic rhinosinusitis (CRS) with polyps and allergic rhinitis than controls. Dabholkar, et al. 18 reported that there was no difference in levels of NO between healthy control and common cold patients, whereas nNO levels was significantly lower in patients with chronic rhinosinusitis. Bommarito, et al. 19 and Liu, et al. 13 postulated that nNO levels could be used as marker to distinguish between chronic rhinosinusitis with nasal polyps (CRSwNP) and chronic rhinosinusitis without nasal polyps (CRSsNP). They found significantly lower levels of nNO in patients with CRSwNP compared to that in patients with CRSsNP and controls. Conversely, nNO concentrations increased significantly in patients with chronic rhinosinusitis (CRS) after endoscopic sinus surgery, this was reported by Fu, et al. 16 and Lee, et al. 21 studies. Fu, et al. 16 showed that nNO levels was higher in CRSsNP group than that in CRSwNP group. Their results revealed that, nNO levels were increased significantly in both groups, and this increasing in nNO levels was related to better quality of life for three months postoperative. At the same time, Lee, et al. 21 found a significant increase in nNO levels from baseline to one month and six months postoperatively. Furthermore, Vaidyanathan, et al. 20 detected increase in the levels of nNO after two weeks of oral steroid therapy in the CRSNP. They showed that in their results, nNO is more sensitive than exhalation and aspiration and is associated with improvements in some symptoms as size of polyp, and quality of life. In the study of Asano, et al 14 higher levels of nNO was measured in asthmatics with rhinitis patients more than those without upper airway infections and those with CRS. Higher concentrations of nNO reflect the presence of allergic rhinitis, irrespective of asthma concomitance.
DISCUSSION
Chronic rhinosinusitis has been regarded as a global health concern; which impacts directly the quality of life of patients and raises the economic and social burden 22, 23 . The diagnosis of CRS is usually conducted by nasal endoscopy or by estimating the history of nasal symptoms. As well as sinus computed tomography (CT) is employed to diagnose the CRS 22 . But these clinical tools may not reflect the severity of inflammation in the nasal cavity or in sinuses 24 . Therefore, the recent studies focused on using some clinical biomarkers as alternative tools which could be used to detect the presence and the degree of inflammation in sinuses 25, 26 . In this systematic review, the role of nasal nitric oxide as biomarker to monitor chronic rhinosinusitis (CRS) was evaluated. The lack of NO may play a role in the pathogenesis of this disease, so this change in nNO amount can be easily measured and provides a valuable non-invasive marker for chronic rhinosinusitis. Overall, significantly lower levels of Nasal NO were reported in the patients with chronic rhinosinusitis (CRS) (irrespective of nasal polyps or allergic 18 indicated that, the lack of nNO is attributed to the pathogenesis of chronic rhinosinusitis. Furthermore, Bommarito, et al. 19 and Liu, et al. 13 stated that nNO levels were significantly lower in patients with CRSwNP than that in patients with CRSsNP and controls, these significant differences in the nNO levels have been used to distinguish between chronic rhinosinusitis patient with nasal polyps (NP) and chronic rhinosinusitis patient without nasal polyps (NP). These results agree with that recorded in study of Fu, et al. 16 when the nNO levels reduced significantly in the patients with CRSwNP compared to that in patients with CRSsNP. On the other hand, after endoscopic sinus surgery or steroidal therapy a highly and significant increasing in the nNO levels were detected in the CRS patient compared to preoperative or pretherapy stage, Fu, et al. 16 ; Lee, et al 21 and Vaidyanathan, et al 20 . A significant increasing in the nNO levels was detected at the third and six month after surgery in the CRSwNP and CRSsNP groups respectively Fu, et al. 16 . Tabaee 27 showed that healing sinonasal tract, mucociliary function occurred three months after surgery of CRSwNP. It was reported that, nNO produced by the inducible nitric oxide synthases (iNOS) in sinus mucosa Fu, et al. 16 . Furthermore Lundberg, et al.demonstrated that, large amount of NO was continuously produced by inducible NO synthase (iNOS) in the healthy or non-inflamed paranasal sinus epithelium.
CONCLUSIONS
It is concluded that, nasal nitric oxide could be employed as a good biomarker for monitoring the sinus health. The lower levels of nasal NO are indicators to the incidence of chronic sinus inflammation in the chronic rhinosinusitis (CRS) patients. These lower levels of nNO increase significantly after sinus therapy or surgical treatment.
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